BANK VONTOBEL/CALL/STRYKER CORP./310/0.1/20.09.24 Share Price

Warrant

DE000VM7NU99

Market Closed - Deutsche Boerse AG 11:20:27 31/05/2024 pm IST
3.71 EUR +0.27% Intraday chart for BANK VONTOBEL/CALL/STRYKER CORP./310/0.1/20.09.24
1 month-6.31%
3 months-27.96%
Date Price Change
31/24/31 3.71 +0.27%
30/24/30 3.7 -4.39%
29/24/29 3.87 +11.53%
28/24/28 3.47 +2.06%
27/24/27 3.4 +1.80%

Delayed Quote Deutsche Boerse AG

Last update May 31, 2024 at 11:20 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VM7NU9
ISINDE000VM7NU99
Date issued 29/12/2023
Strike 310 $
Maturity 20/09/2024 (110 Days)
Parity 10 : 1
Emission price 2.21
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 5.95
Lowest since issue 1.94
Delta0.8x
Omega 6.657
Premium2.99x
Gearing8.36x
Moneyness 1.099
Difference Strike -30.57 $
Difference Strike %-9.86%
Spread 0.03
Spread %0.80%
Intrinsic value 2.818

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
341.1 USD
Average target price
373.1 USD
Spread / Average Target
+9.38%
Consensus